Karmanos Cancer Institute ( Site 0018) — Detroit, Michigan

Karmanos Cancer Institute ( Site 0018) is a clinical research site located in Detroit, Michigan, United States 48201.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Karmanos Cancer Institute ( Site 0018) has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Uterine Cervical Neoplasms, Non-small Cell Lung Cancer (NSCLC).

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Karmanos Cancer Institute ( Site 0018)?

Karmanos Cancer Institute ( Site 0018) has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Karmanos Cancer Institute ( Site 0018) conducted?

Karmanos Cancer Institute ( Site 0018) has 2 clinical trials on record, with 1 currently active. Their work covers Uterine Cervical Neoplasms, Non-small Cell Lung Cancer (NSCLC).

Is Karmanos Cancer Institute ( Site 0018) accredited by Crixeo Health?

Karmanos Cancer Institute ( Site 0018) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Karmanos Cancer Institute ( Site 0018)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.